▶ 調査レポート

手湿疹(HE)治療の世界市場2023:ステロイド外用剤、その他

• 英文タイトル:Global Hand Eczema (HE) Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。手湿疹(HE)治療の世界市場2023:ステロイド外用剤、その他 / Global Hand Eczema (HE) Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC2306GIR0618資料のイメージです。• レポートコード:MRC2306GIR0618
• 出版社/出版日:GlobalInfoResearch / 2023年6月
• レポート形態:英語、PDF、104ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医薬品&医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
GlobalInfoResearchの最新の調査によると、世界の手湿疹(HE)治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の手湿疹(HE)治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 手湿疹(HE)治療の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

手湿疹(HE)治療市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・ステロイド外用剤、その他

用途別セグメント
・病院、薬局、オンライン

主要な市場プレーヤー
・Novartis、Johnson & Johnson、Sanofi、Pfizer、Abbott、Roche、Merck & Co. Inc.、Eli Lilly、Bayer、GlaxoSmithKline、Galderma、Taro Pharmaceuticals、Aqua Pharmaceuticals、Arbor Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、手湿疹(HE)治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な手湿疹(HE)治療メーカーの企業概要、2019年~2022年までの手湿疹(HE)治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な手湿疹(HE)治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別手湿疹(HE)治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの手湿疹(HE)治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での手湿疹(HE)治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および手湿疹(HE)治療の産業チェーンを掲載しています。
・第14、15章では、手湿疹(HE)治療の販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- 手湿疹(HE)治療の概要
- 種類別分析(2018年vs2022年vs2029年):ステロイド外用剤、その他
- 用途別分析(2018年vs2022年vs2029年):病院、薬局、オンライン
- 世界の手湿疹(HE)治療市場規模・予測
- 世界の手湿疹(HE)治療生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Novartis、Johnson & Johnson、Sanofi、Pfizer、Abbott、Roche、Merck & Co. Inc.、Eli Lilly、Bayer、GlaxoSmithKline、Galderma、Taro Pharmaceuticals、Aqua Pharmaceuticals、Arbor Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:ステロイド外用剤、その他
・用途別分析2018年-2029年:病院、薬局、オンライン
・手湿疹(HE)治療の北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・手湿疹(HE)治療のヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・手湿疹(HE)治療のアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・手湿疹(HE)治療の南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・手湿疹(HE)治療の中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Hand Eczema (HE) Treatment market size was valued at USD 46 million in 2022 and is forecast to a readjusted size of USD 74 million by 2029 with a CAGR of 7.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hand eczema is one of the most common types of eczema. It mainly affects the palms but can affect other parts of the hand, too. The main symptoms are dry, itchy skin that is red or darker than the surrounding skin. Other symptoms include cracking, soreness and bleeding. Topical steroids treat flaring eczema by reducing inflammation, helping skin that is sore, cracked and red or darker than the surrounding skin. Hands usually require stronger steroids (the skin of the palms is thick), so potent topical steroids are usually prescribed.
This report is a detailed and comprehensive analysis for global Hand Eczema (HE) Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hand Eczema (HE) Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hand Eczema (HE) Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hand Eczema (HE) Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hand Eczema (HE) Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hand Eczema (HE) Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hand Eczema (HE) Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Johnson & Johnson, Sanofi, Pfizer and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Hand Eczema (HE) Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Topical Steroid
Others
Market segment by Application
Hospital
Retail Pharmacies
Online
Major players covered
Novartis
Johnson & Johnson
Sanofi
Pfizer
Abbott
Roche
Merck & Co. Inc.
Eli Lilly
Bayer
GlaxoSmithKline
Galderma
Taro Pharmaceuticals
Aqua Pharmaceuticals
Arbor Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hand Eczema (HE) Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hand Eczema (HE) Treatment, with price, sales, revenue and global market share of Hand Eczema (HE) Treatment from 2018 to 2023.
Chapter 3, the Hand Eczema (HE) Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hand Eczema (HE) Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hand Eczema (HE) Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hand Eczema (HE) Treatment.
Chapter 14 and 15, to describe Hand Eczema (HE) Treatment sales channel, distributors, customers, research findings and conclusion.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Hand Eczema (HE) Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hand Eczema (HE) Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Topical Steroid
1.3.3 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Hand Eczema (HE) Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacies
1.4.4 Online
1.5 Global Hand Eczema (HE) Treatment Market Size & Forecast
1.5.1 Global Hand Eczema (HE) Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hand Eczema (HE) Treatment Sales Quantity (2018-2029)
1.5.3 Global Hand Eczema (HE) Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Hand Eczema (HE) Treatment Product and Services
2.1.4 Novartis Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Hand Eczema (HE) Treatment Product and Services
2.2.4 Johnson & Johnson Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Hand Eczema (HE) Treatment Product and Services
2.3.4 Sanofi Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Hand Eczema (HE) Treatment Product and Services
2.4.4 Pfizer Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments/Updates
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Hand Eczema (HE) Treatment Product and Services
2.5.4 Abbott Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abbott Recent Developments/Updates
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Hand Eczema (HE) Treatment Product and Services
2.6.4 Roche Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Roche Recent Developments/Updates
2.7 Merck & Co. Inc.
2.7.1 Merck & Co. Inc. Details
2.7.2 Merck & Co. Inc. Major Business
2.7.3 Merck & Co. Inc. Hand Eczema (HE) Treatment Product and Services
2.7.4 Merck & Co. Inc. Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck & Co. Inc. Recent Developments/Updates
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Hand Eczema (HE) Treatment Product and Services
2.8.4 Eli Lilly Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eli Lilly Recent Developments/Updates
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Hand Eczema (HE) Treatment Product and Services
2.9.4 Bayer Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bayer Recent Developments/Updates
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Hand Eczema (HE) Treatment Product and Services
2.10.4 GlaxoSmithKline Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GlaxoSmithKline Recent Developments/Updates
2.11 Galderma
2.11.1 Galderma Details
2.11.2 Galderma Major Business
2.11.3 Galderma Hand Eczema (HE) Treatment Product and Services
2.11.4 Galderma Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Galderma Recent Developments/Updates
2.12 Taro Pharmaceuticals
2.12.1 Taro Pharmaceuticals Details
2.12.2 Taro Pharmaceuticals Major Business
2.12.3 Taro Pharmaceuticals Hand Eczema (HE) Treatment Product and Services
2.12.4 Taro Pharmaceuticals Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Taro Pharmaceuticals Recent Developments/Updates
2.13 Aqua Pharmaceuticals
2.13.1 Aqua Pharmaceuticals Details
2.13.2 Aqua Pharmaceuticals Major Business
2.13.3 Aqua Pharmaceuticals Hand Eczema (HE) Treatment Product and Services
2.13.4 Aqua Pharmaceuticals Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Aqua Pharmaceuticals Recent Developments/Updates
2.14 Arbor Pharmaceuticals
2.14.1 Arbor Pharmaceuticals Details
2.14.2 Arbor Pharmaceuticals Major Business
2.14.3 Arbor Pharmaceuticals Hand Eczema (HE) Treatment Product and Services
2.14.4 Arbor Pharmaceuticals Hand Eczema (HE) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Arbor Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Hand Eczema (HE) Treatment by Manufacturer
3.1 Global Hand Eczema (HE) Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hand Eczema (HE) Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Hand Eczema (HE) Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hand Eczema (HE) Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hand Eczema (HE) Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Hand Eczema (HE) Treatment Manufacturer Market Share in 2022
3.5 Hand Eczema (HE) Treatment Market: Overall Company Footprint Analysis
3.5.1 Hand Eczema (HE) Treatment Market: Region Footprint
3.5.2 Hand Eczema (HE) Treatment Market: Company Product Type Footprint
3.5.3 Hand Eczema (HE) Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Hand Eczema (HE) Treatment Market Size by Region
4.1.1 Global Hand Eczema (HE) Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Hand Eczema (HE) Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Hand Eczema (HE) Treatment Average Price by Region (2018-2029)
4.2 North America Hand Eczema (HE) Treatment Consumption Value (2018-2029)
4.3 Europe Hand Eczema (HE) Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Hand Eczema (HE) Treatment Consumption Value (2018-2029)
4.5 South America Hand Eczema (HE) Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Hand Eczema (HE) Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Hand Eczema (HE) Treatment Sales Quantity by Type (2018-2029)
5.2 Global Hand Eczema (HE) Treatment Consumption Value by Type (2018-2029)
5.3 Global Hand Eczema (HE) Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Hand Eczema (HE) Treatment Sales Quantity by Application (2018-2029)
6.2 Global Hand Eczema (HE) Treatment Consumption Value by Application (2018-2029)
6.3 Global Hand Eczema (HE) Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Hand Eczema (HE) Treatment Sales Quantity by Type (2018-2029)
7.2 North America Hand Eczema (HE) Treatment Sales Quantity by Application (2018-2029)
7.3 North America Hand Eczema (HE) Treatment Market Size by Country
7.3.1 North America Hand Eczema (HE) Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Hand Eczema (HE) Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Hand Eczema (HE) Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Hand Eczema (HE) Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Hand Eczema (HE) Treatment Market Size by Country
8.3.1 Europe Hand Eczema (HE) Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Hand Eczema (HE) Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Hand Eczema (HE) Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hand Eczema (HE) Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hand Eczema (HE) Treatment Market Size by Region
9.3.1 Asia-Pacific Hand Eczema (HE) Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hand Eczema (HE) Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Hand Eczema (HE) Treatment Sales Quantity by Type (2018-2029)
10.2 South America Hand Eczema (HE) Treatment Sales Quantity by Application (2018-2029)
10.3 South America Hand Eczema (HE) Treatment Market Size by Country
10.3.1 South America Hand Eczema (HE) Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Hand Eczema (HE) Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Hand Eczema (HE) Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hand Eczema (HE) Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hand Eczema (HE) Treatment Market Size by Country
11.3.1 Middle East & Africa Hand Eczema (HE) Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hand Eczema (HE) Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Hand Eczema (HE) Treatment Market Drivers
12.2 Hand Eczema (HE) Treatment Market Restraints
12.3 Hand Eczema (HE) Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Hand Eczema (HE) Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hand Eczema (HE) Treatment
13.3 Hand Eczema (HE) Treatment Production Process
13.4 Hand Eczema (HE) Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hand Eczema (HE) Treatment Typical Distributors
14.3 Hand Eczema (HE) Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer